Search results
EXCLUSIVE: LVMH Picks Up Clockmaker L’Épée 1839
WWD via Yahoo Singapore Finance· 2 weeks agoWith the acquisition of the high-end specialist and its parent company Swiza, the French luxury group is strengthening its watchmaking division, now...
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Singapore Finance· 1 month agoIn recent trading, the Swiss market demonstrated resilience, with the benchmark SMI index closing modestly higher after a day of fluctuating gains and...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Zacks via Yahoo Singapore Finance· 1 month agoNovartis NVS announced results from the six-month, double-blind trial period of the late-stage...
individual investors who own 60% along with institutions invested in Sandoz Group AG (VTX:SDZ) saw...
Simply Wall St. via Yahoo Singapore Finance· 2 months agoKey Insights The considerable ownership by individual investors in Sandoz Group indicates that they...
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via Yahoo Singapore Finance· 2 months agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer ...
CVS stock plunges after earnings numbers one analyst 'did not even believe'
Yahoo Finance· 2 months agoCVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Singapore Finance· 2 months agoNovartis AG (NYSE:NVS) is one of the largest pharmaceutical companies in the world, many of whose drugs are "gold standards" in the treatment of cancer,...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Benzinga via Yahoo Singapore Finance· 2 months agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on...
Sandoz reaches agreement with Amgen over patent dispute
Reuters via Yahoo Singapore Finance· 2 months agoSwiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. denosumab biosimilars ...
Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoEvotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript April 24, 2024 Evotec SE misses on earnings...
